Literature DB >> 18049292

DSM-IV diagnoses and obstructive sleep apnea in children before and 1 year after adenotonsillectomy.

James E Dillon1, Sarah Blunden, Deborah L Ruzicka, Kenneth E Guire, Donna Champine, Robert A Weatherly, Elise K Hodges, Bruno J Giordani, Ronald D Chervin.   

Abstract

OBJECTIVE: Obstructive sleep apnea, a common indication for adenotonsillectomy in children, has been linked to behavioral morbidity. We assessed psychiatric diagnoses in children before and after adenotonsillectomy and examined whether baseline sleep apnea predicted improvement after surgery.
METHOD: Subjects of this prospective cohort study were children ages 5.0 to 12.9 years old who had been scheduled for adenotonsillectomy (n = 79) or care for unrelated surgical conditions (n = 27, among whom 13 had surgery after baseline assessment). Before intervention and 1 year later, subjects underwent structured diagnostic interviews and polysomnography. The main outcome measure was frequency of DSM-IV attention and disruptive behavior disorder diagnoses at baseline and follow-up.
RESULTS: At baseline, attention and disruptive behavior disorders were diagnosed in 36.7% of adenotonsillectomy subjects and 11.1% of controls (p < .05); attention-deficit/hyperactivity disorder was found in 27.8% and 7.4%, respectively (p < .05). One year later, group differences were nonsignificant; attention and disruptive behavior disorders were diagnosed in only 23.1% (p < .01), and 50% of subjects with baseline attention-deficit/hyperactivity disorder no longer met diagnostic criteria. Obstructive sleep apnea on polysomnography at baseline did not predict concurrent psychiatric morbidity or later improvement.
CONCLUSIONS: Attention and disruptive behavior disorders, diagnosed by DSM-IV criteria, were more common before clinically indicated adenotonsillectomy than 1 year later. Surgery may be associated with reduced morbidity, even among subjects lacking polysomnographic evidence of obstructive sleep apnea.

Entities:  

Mesh:

Year:  2007        PMID: 18049292      PMCID: PMC2408827          DOI: 10.1097/chi.0b013e31814b8eb2

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  45 in total

1.  Review of the use of pattern analysis to differentiate true drug and placebo responses.

Authors:  R Rothschild; F M Quitkin
Journal:  Psychother Psychosom       Date:  1992       Impact factor: 17.659

2.  The effect of tonsillectomy and adenoidectomy on inattention and impulsivity as measured by the Test of Variables of Attention (TOVA) in children with obstructive sleep apnea syndrome.

Authors:  Galit Avior; Gadi Fishman; Agnes Leor; Yakov Sivan; Nehemia Kaysar; Ari Derowe
Journal:  Otolaryngol Head Neck Surg       Date:  2004-10       Impact factor: 3.497

3.  Sleep apnea in eight children.

Authors:  C Guilleminault; F L Eldridge; F B Simmons; W C Dement
Journal:  Pediatrics       Date:  1976-07       Impact factor: 7.124

4.  Sleep-disordered breathing symptoms are associated with poorer cognitive function in 5-year-old children.

Authors:  Daniel J Gottlieb; Cynthia Chase; Richard M Vezina; Timothy C Heeren; Michael J Corwin; Sanford H Auerbach; Debra E Weese-Mayer; Samuel M Lesko
Journal:  J Pediatr       Date:  2004-10       Impact factor: 4.406

5.  Upper airway resistance syndrome: sick, symptomatic but underrecognized.

Authors:  R Downey; R M Perkin; J MacQuarrie
Journal:  Sleep       Date:  1993-10       Impact factor: 5.849

6.  Sleep disorders in Taiwanese children with attention deficit/hyperactivity disorder.

Authors:  Yu-Shu Huang; Ning-Hung Chen; Hsueh-Yu Li; Yu-Yu Wu; Chia-Chen Chao; Christian Guilleminault
Journal:  J Sleep Res       Date:  2004-09       Impact factor: 3.981

7.  A children's global assessment scale (CGAS).

Authors:  D Shaffer; M S Gould; J Brasic; P Ambrosini; P Fisher; H Bird; S Aluwahlia
Journal:  Arch Gen Psychiatry       Date:  1983-11

8.  Clinical assessment of pediatric obstructive sleep apnea.

Authors:  Nira A Goldstein; Vasanthi Pugazhendhi; Sudha M Rao; Jeremy Weedon; Thomas F Campbell; Andrew C Goldman; J Christopher Post; Madu Rao
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

9.  Ontario Child Health Study. II. Six-month prevalence of disorder and rates of service utilization.

Authors:  D R Offord; M H Boyle; P Szatmari; N I Rae-Grant; P S Links; D T Cadman; J A Byles; J W Crawford; H M Blum; C Byrne
Journal:  Arch Gen Psychiatry       Date:  1987-09

10.  Psychiatric symptoms in children with insomnia referred to a pediatric sleep medicine center.

Authors:  Anna Ivanenko; Maria E Barnes; Valerie McLaughlin Crabtree; David Gozal
Journal:  Sleep Med       Date:  2004-05       Impact factor: 3.492

View more
  19 in total

1.  The Childhood Adenotonsillectomy Trial (CHAT): rationale, design, and challenges of a randomized controlled trial evaluating a standard surgical procedure in a pediatric population.

Authors:  Susan Redline; Raouf Amin; Dean Beebe; Ronald D Chervin; Susan L Garetz; Bruno Giordani; Carole L Marcus; Renee H Moore; Carol L Rosen; Raanan Arens; David Gozal; Eliot S Katz; Ronald B Mitchell; Hiren Muzumdar; H G Taylor; Nina Thomas; Susan Ellenberg
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

2.  Depressive symptomatology in school-aged children with obstructive sleep apnea syndrome: incidence, demographic factors, and changes following a randomized controlled trial of adenotonsillectomy.

Authors:  Elise Hodges; Carole L Marcus; Ji Young Kim; Melissa Xanthopoulos; Justine Shults; Bruno Giordani; Dean W Beebe; Carol L Rosen; Ronald D Chervin; Ron B Mitchell; Eliot S Katz; David Gozal; Susan Redline; Lisa Elden; Raanan Arens; Renee Moore; H Gerry Taylor; Jerilynn Radcliffe; Nina H Thomas
Journal:  Sleep       Date:  2018-12-01       Impact factor: 5.849

3.  Aggressive behavior, bullying, snoring, and sleepiness in schoolchildren.

Authors:  Louise M O'Brien; Neali H Lucas; Barbara T Felt; Timothy F Hoban; Deborah L Ruzicka; Ruth Jordan; Kenneth Guire; Ronald D Chervin
Journal:  Sleep Med       Date:  2011-05-26       Impact factor: 3.492

4.  Risk of behavioral and adaptive functioning difficulties in youth with previous and current sleep disordered breathing.

Authors:  Michelle M Perfect; Kristen Archbold; James L Goodwin; Deborah Levine-Donnerstein; Stuart F Quan
Journal:  Sleep       Date:  2013-04-01       Impact factor: 5.849

Review 5.  Executive summary of respiratory indications for polysomnography in children: an evidence-based review.

Authors:  Merrill S Wise; Cynthia D Nichols; Madeleine M Grigg-Damberger; Carole L Marcus; Manisha B Witmans; Valerie G Kirk; Lynn A D'Andrea; Timothy F Hoban
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

6.  Sleep disturbances and neurobehavioral functioning in children with and without juvenile idiopathic arthritis.

Authors:  Teresa M Ward; Sarah Ringold; Jonika Metz; Kristen Archbold; Martha Lentz; Carol A Wallace; Carol A Landis
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-07       Impact factor: 4.794

7.  The relationship between depressive symptoms and obstructive sleep apnea in pediatric populations: a meta-analysis.

Authors:  Elif Yilmaz; Karim Sedky; David S Bennett
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

8.  Sleep stage dynamics differ between children with and without obstructive sleep apnea.

Authors:  Ronald D Chervin; Judith L Fetterolf; Deborah L Ruzicka; Brian J Thelen; Joseph W Burns
Journal:  Sleep       Date:  2009-10       Impact factor: 5.849

Review 9.  Pediatric Obstructive Sleep Apnea and Asthma: Clinical Implications.

Authors:  Michelle Trivedi; Mai ElMallah; Evan Bailey; Ted Kremer; Lawrence M Rhein
Journal:  Pediatr Ann       Date:  2017-09-01       Impact factor: 1.132

10.  Long-term changes in neurocognition and behavior following treatment of sleep disordered breathing in school-aged children.

Authors:  Sarah N Biggs; Anna Vlahandonis; Vicki Anderson; Robert Bourke; Gillian M Nixon; Margot J Davey; Rosemary S C Horne
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.